[A15-09] Apremilast - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Last updated 15.05.2015
Project no.:
A15-09
Commission:
Commission awarded on 16.02.2015 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Skin and hair, Muscles, bones and joints
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Accompanying information| Project no. | Title | Status |
|---|---|---|
| A20-44 | Apremilast (Behçet’s disease) - Benefit assessment according to §35a Social Code Book V | Commission completed |